Back to Search

LAURIE MORTARA, MD

MD

Internal Medicine Physician

NPI: 1932216124IndividualAccepts Medicare

Specialties, Licenses & Credentials

Infectious Disease Physician

Internal Medicine — Infectious Disease

Code: 207RI0200X

G64673(CA)
Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

G64673(CA)

CMS Specialties

PrimaryINFECTIOUS DISEASE

Additional

INTERNAL MEDICINE

Education

UNIVERSITY OF HAWAII JOHN A. BURNS SCHOOL OF MEDICINE

Class of 1987

Research & Publications (20)

Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.
PMID 19395374·Int Immunol·2009
7-preclinical
Experimental therapeutic approaches to adenocarcinoma: the potential of tumor cells engineered to express MHC class II molecules combined with naked DNA interleukin-12 gene transfer.
PMID 18035537·Surg Oncol·2007
6-review
Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan.
PMID 18022863·Eur J Immunol·2007
7-preclinical
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
PMID 16740768·Clin Cancer Res·2006
7-preclinical
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.
PMID 19325034·Int Immunol·2009
8-other
Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study.
PMID 19014658·Thyroid Res·2008
8-other
Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome.
PMID 18385227·J Virol·2008
7-preclinical
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions.
PMID 18087678·Cancer Metastasis Rev·2008
6-review
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251.
PMID 16945152·Virol J·2006
7-preclinical
Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
PMID 16908858·Proc Natl Acad Sci U S A·2006
7-preclinical
Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin.
PMID 16638868·Clin Cancer Res·2006
7-preclinical
Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes.
PMID 16325847·J Immunol Methods·2006
4-observational
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS.
PMID 15761496·J Clin Invest·2005
7-preclinical
Sequential immunogene therapy with interleukin-12- and interleukin-15-engineered neuroblastoma cells cures metastatic disease in syngeneic mice.
PMID 15701863·Clin Cancer Res·2005
7-preclinical
The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells.
PMID 15627980·Eur J Immunol·2005
8-other
DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm.
PMID 14694112·J Virol·2004
7-preclinical
Grading of laboratories on CD4+ T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error.
PMID 12116354·Cytometry·2002
8-other
Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication.
PMID 11907251·J Virol·2002
7-preclinical
Analysis of the antigen specific T cell repertoires in HIV infection.
PMID 11595293·Immunol Lett·2001
8-other
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
PMID 11118377·Virology·2000
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2110 N BELLFLOWER BLVD
LONG BEACH, CA 90815

Location

Practice Location

2110 N BELLFLOWER BLVD, LONG BEACH, CA
(562) 346-2222

Quick Facts

NPI
1932216124
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
39
Publications
20

Are you this provider?

Claim Your Profile